genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Biotie Therapies
Industry News
Acorda Acquires Biotie Therapies for $363M
Industry News
Neurelis, Biotie Therapies Enter Option and Merger Agreement
Drug Discovery
Biotie Regains Asia-Pacific Rights for VAP-1 Antibody Program from Seikagaku
Industry News
Biotie Axes Agreement to Acquire Newron on Latter’s Loss of Partner for Parkinson Disease Drug
News
Biotie to Buy Newron in €45M Share-Based Deal
Industry News
Biotie to Acquire CNS Therapeutics Firm Synosia in €93.6M All-Shares Deal
News
Lundbeck and Biotie Report Alcohol Dependence Therapy Success in Two Phase III Studies
News
Biotie Restructures to Focus on Clinical Pipeline Headed by Lundbeck-Partnered Nalmefene
News
Biotie to Take Over Elbion in Share-Exchange Transaction
Scroll Up
Scroll Up
